09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Also, a trend was observed correlating increased cancer risk with increased severity of exposure.<br />

Workers in the moderate exposure group with a probable latent period of at least 15 years exhibited 13<br />

cases of cancer of all types vs. 5.5 expected, and 5 cases of lung cancer vs. 1.4 expected (p < 0.05).<br />

One potential confounding factor in this study is the lack of controls for tobacco smoking. US EPA<br />

(1983) investigated the possible impact of smoking on lung cancer incidence in the O’Berg (1980)<br />

study. DuPont provided additional data on 32 of 36 cancer cases reported on in the plant under study<br />

(some cases were not in the study cohort) and on smoking data for a matched group of non-cancer<br />

cases. Of the 32 cancer cases for which smoking data was available, 22 were cancer types other than<br />

lung, and 16 of the non-lung cancer cases (73%) were smokers. Of the matched noncancer controls,<br />

25 (69%) were smokers. US EPA estimated that 70% of the plant population were smokers and 30%<br />

nonsmokers, and of the smoker population, 50% were “moderate” smokers and 20% were “heavy”<br />

smokers. Based on the assumption that the relative risk of lung cancer for nonsmokers, moderate, and<br />

heavy smokers is 1, 10 and 20, respectively, US EPA adjusted the number of expected lung cancer<br />

cases in the study cohort to reflect the smoking prevalence data. The number of expected lung cancer<br />

cases after adjustment for smoking is 1.61 cases. This is about 15% higher than the 1.4 cases expected<br />

without considering smoking differences; however, this adjustment did not substantially alter the<br />

significance of the increased prevalence of lung cancer in the workers exposed to acrylonitrile. US EPA<br />

(1983) concluded that the observations by O’Berg (1980) of a statistically significant excess of lung<br />

cancer in acrylonitrile-exposed workers constitutes significant evidence that acrylonitrile is likely to be a<br />

human carcinogen.<br />

A followup to the O’Berg (1980) study was conducted by O’Berg et al. (1985). Observations of<br />

cancer incidence and mortality for the study cohort of 1345 DuPont workers exposed to acrylonitrile<br />

was extended through 1981 for mortality and through 1983 for cancer incidence. Exposed workers<br />

demonstrated 43 cases of all types of cancer, with 37.1 expected. Of these cases, 10 were lung cancer<br />

versus 4.4 expected. These rates were in excess but were not statistically significant. Additionally,<br />

prostate cancer rates were significantly elevated, with 6 cases observed compared to 1.8 cases<br />

expected (p < 0.05).<br />

Theiss et al. (1980) (reviewed by US EPA, 1983) conducted a cohort mortality study of 1469 workers<br />

from 12 factories owned by the BASF company in the Federal Republic of Germany (FRG). BASF<br />

purchased acrylonitrile during the study period in order to produce styrene-acrylonitrile and<br />

acrylonitrile-butadiene-styrene polymers in addition to organic intermediate products. Processing<br />

methods differed between factories, and worker exposure data was not available. The study population<br />

was defined as all workers employed for over 6 months in acrylonitrile processing from the time of first<br />

use of acrylonitrile (approximately 1956) to the study cut-off date of May 15, 1978. The cohort<br />

included 1081 German workers and 338 workers of other nationalities. Followup was 98% complete<br />

on the German workers, but only 56% complete on the foreign workers. Expected deaths were<br />

calculated from mortality rates for the city of Ludwigshafen, the state of Rheinhessen-Pfalz, and the<br />

FRG as a <strong>whole</strong>. An elevated risk of cancer (all types) mortality was noted in the study cohort (27<br />

observed, 20.5 expected based on FRG mortality rates). The study cohort also demonstrated a<br />

significantly elevated risk of lung cancer (11 observed, 5.65 expected based on FRG rates, p < 0.05;<br />

40

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!